|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
1.440 +0.060 (+4.348%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 2,379,631 | 13.096% | 2,104,083 | 696,958 | 323,057 | 210,033 | |
| Cost of Sales | (1,563,952) | 7.629% | (1,453,102) | (392,092) | (167,184) | (104,576) | |
| Gross Profit | 815,679 | 25.300% | 650,981 | 304,866 | 155,873 | 105,457 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (363,539) | -- | 181,738 | (443,136) | 181,580 | 47,515 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (17,909) | (24,274) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (487) | (1,908) | (3,246) | |
| Profit / (Loss) before Taxation | (459,165) | -- | 347,701 | (356,210) | 280,925 | 105,861 | |
| Taxation | (45,055) | -4.425% | (47,141) | (22,660) | (15,053) | (15,311) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (24,255) | 86.376% | (13,014) | (8,010) | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (528,475) | -- | 287,546 | (386,880) | 265,872 | 90,550 | |
| Net Finance Costs / (Income) | 163,068 | 4.175% | 156,533 | 45,424 | (12,825) | (304) | |
| Depreciation & Amortisation | 178,301 | 18.197% | 150,851 | 68,660 | 33,638 | 9,548 | |
| Directors' Emoluments | -- | -- | 9,187 | 6,534 | 7,995 | 5,643 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | -28.000 | -- | 15.000 | -25.000 | 19.000 | 8.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 2.277 | 1.818 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 9.570% | -- |
| Cash flow per share ($) | -- | -- | 0.041 | 0.027 | 0.033 | 0.011 |
| NBV per share ($) | 1.643 | -- | 1.780 | 1.714 | 1.138 | -- |
| Remarks: | Real time quote last updated: 29/05/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -528,475 |
| %Change | -- |
| EPS / (LPS) | RMB -0.280 |
| NBV Per Share (¥) | RMB 1.643 |